NYSE - Nasdaq Real Time Price USD

LyondellBasell Industries N.V. (LYB)

101.99 +2.31 (+2.32%)
As of 2:06 PM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 18182423
Avg. Estimate 1.362.248.269.85
Low Estimate 1.11.986.868.36
High Estimate 1.52.5910.4511.7
Year Ago EPS 2.512.448.788.26

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 14142020
Avg. Estimate 9.73B10.35B40.91B35.34B
Low Estimate 9.06B9.88B38.09B32.14B
High Estimate 10.28B11.2B46.92B40.81B
Year Ago Sales 10.25B10.79B41.11B40.91B
Sales Growth (year/est) -5.00%-4.10%-0.50%-13.60%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 1.742.282.031.31
EPS Actual 2.512.442.461.39
Difference 0.770.160.430.08
Surprise % 44.30%7.00%21.20%6.10%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 1.362.248.269.85
7 Days Ago 1.362.248.269.85
30 Days Ago 1.412.248.49.96
60 Days Ago 1.412.238.499.94
90 Days Ago 1.672.389.2610.46

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days 1------
Up Last 30 Days 4442
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD LYBIndustrySectorS&P 500
Current Qtr. -45.80%----1.50%
Next Qtr. -8.20%----12.10%
Current Year -5.90%----4.40%
Next Year 19.20%----13.20%
Next 5 Years (per annum) 8.43%----10.97%
Past 5 Years (per annum) 2.84%------

Research Analysis

Analyst Price Targets

85.00 Low
103.13 Average
101.99 Current
120.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Citigroup: Neutral to Neutral 4/10/2024
Maintains Barclays: Equal-Weight to Equal-Weight 4/4/2024
Maintains Wells Fargo: Overweight to Overweight 4/2/2024
Maintains JP Morgan: Overweight to Overweight 3/22/2024
Initiated Wolfe Research: Underperform 3/1/2024
Reiterates RBC Capital: Outperform to Outperform 2/5/2024

Related Tickers